an experimental experience

7/19/23 at 4:20pm

Organization

Authors

38 words

Comments

Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but not in settings with low HIV incidence.

You are the first to view

https://www.pharmacytimes.com/view/rollout-of-long-acting-cabotegravir-without-delay-can-have-greatest-impact-on-hiv-prep

Create an account or login to join the discussion